Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Baxter International Inc (BAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,157,404
  • Shares Outstanding, K 544,830
  • Annual Sales, $ 10,163 M
  • Annual Income, $ 4,965 M
  • 36-Month Beta 0.69
  • Price/Sales 3.67
  • Price/Cash Flow 19.60
  • Price/Book 3.90

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.41 +7.44%
on 12/22/17
69.65 -0.65%
on 01/09/18
+3.75 (+5.73%)
since 12/18/17
3-Month
62.52 +10.68%
on 10/25/17
69.65 -0.65%
on 01/09/18
+5.36 (+8.40%)
since 10/18/17
52-Week
45.47 +52.19%
on 01/24/17
69.65 -0.65%
on 01/09/18
+22.43 (+47.96%)
since 01/18/17

Most Recent Stories

More News
Key Factors to Influence PerkinElmer's (PKI) Q4 Earnings

PerkinElmer (PKI) solid product portfolio, positive market trends and acquisition are likely to drive earnings in the fourth quarter.

BIVV : 62.75 (+0.69%)
BAX : 69.20 (+1.47%)
BIO : 252.50 (-0.06%)
PKI : 79.54 (-0.14%)
Watch for Baxter Intl Inc to Potentially Pullback After Gaining 1.51% Yesterday

Baxter Intl Inc (NYSE:BAX) traded in a range yesterday that spanned from a low of $68.32 to a high of $69.47. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $68.62...

BAX : 69.20 (+1.47%)
Baxter to Present at the 7th Annual Leerink Partners Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the 7th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 14, 2018, in New York. Jay Saccaro, Baxter's chief...

BAX : 69.20 (+1.47%)
Baxter (BAX) Launches Arisure Closed System Transfer Device

Baxter's (BAX) Arisure Closed System reduces exposure risk of healthcare professionals to needles. Also, the latest development promotes safe handling of hazardous drugs.

ITGR : 47.90 (-1.03%)
BAX : 69.20 (+1.47%)
BIO : 252.50 (-0.06%)
ISRG : 432.07 (+0.23%)
Baxter Launches Arisure Closed System Transfer Device to Help Prevent Hazardous Drug Exposure and Maintain Medication Sterility

--Helps support compliance with NIOSH and upcoming USP standards

BAX : 69.20 (+1.47%)
Blog Exposure - Baxter International Acquires RECOTHROM and PREVELEAK from Mallinckrodt

Stock Monitor: Mallinckrodt Post Earnings Reporting

BAX : 69.20 (+1.47%)
MNK : 21.70 (-2.60%)
Mallinckrodt (MNK) to Sell Recothrom and Preveleak to Baxter

Mallinckrodt's (MNK) strategy to streamline its business to evolve as a top-performing specialty pharmaceutical company has led the company to enter into an agreement to sell Recothrom and Preveleak to...

SCMP : 17.95 (-0.28%)
MDCO : 25.03 (-1.34%)
BAX : 69.20 (+1.47%)
MNK : 21.70 (-2.60%)
Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter

Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announced today it has entered into an agreement under which it will sell certain hemostasis products to Baxter International Inc....

BAX : 69.20 (+1.47%)
MNK : 21.70 (-2.60%)
Global Intravenous Solutions Market 2017-2022: Key Players are Ajinomoto, B. Braun Melsungen, Baxter International Inc., Grifols and Otsuka Pharmaceutical

The "Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report has been added to Research and Markets' offering.

BAX : 69.20 (+1.47%)
The Zacks Analyst Blog Highlights: Wal-Mart, Citigroup, Qualcomm, Sherwin-Williams and Baxter

The Zacks Analyst Blog Highlights: Wal-Mart, Citigroup, Qualcomm, Sherwin-Williams and Baxter

C : 77.39 (-0.10%)
SHW : 430.76 (+0.89%)
QCOM : 68.05 (+0.04%)
BAX : 69.20 (+1.47%)
WMT : 104.30 (+1.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma etc. As a global, diversified healthcare company, Baxter applies a unique combination...

See More

Key Turning Points

2nd Resistance Point 70.15
1st Resistance Point 69.67
Last Price 69.20
1st Support Level 68.52
2nd Support Level 67.85

See More

52-Week High 69.65
Last Price 69.20
Fibonacci 61.8% 60.41
Fibonacci 50% 57.56
Fibonacci 38.2% 54.71
52-Week Low 45.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.